0

IN THIS ISSUE

Archives of General Psychiatry

April 2005, Vol 62, No. 4
Basic View  |  Expanded View
About This Journal FREE
Topics:
Arch Gen Psychiatry. 2005;62(4):354. doi:10.1001/archpsyc.62.4.354.
This Month in Archives of General Psychiatry FREE
Topics:
Arch Gen Psychiatry. 2005;62(4):358. doi:10.1001/archpsyc.62.4.358.
Excavation
James C. Harris, MD
Topics:
Arch Gen Psychiatry. 2005;62(4):359-360. doi:10.1001/archpsyc.62.4.359.
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis FREE
Jeffrey A. Lieberman, MD; Gary D. Tollefson, MD, PhD; Cecil Charles, PhD; Robert Zipursky, MD; Tonmoy Sharma, MD; Rene S. Kahn, MD, PhD; Richard S. E. Keefe, PhD; Alan I. Green, MD; Raquel E. Gur, MD, PhD; Joseph McEvoy, MD; Diana Perkins, MD, MPH; Robert M. Hamer, PhD; Hongbin Gu, PhD; Mauricio Tohen, MD, DrPH; HGDH Study Group
Topics: magnetic resonance imaging, haloperidol, antipsychotic agents, psychotic disorders, brain, olanzapine, gray matter
Arch Gen Psychiatry. 2005;62(4):361-370. doi:10.1001/archpsyc.62.4.361.
Increased Caudate Dopamine D2 Receptor Availability as a Genetic Marker for Schizophrenia FREE
Jussi Hirvonen, MD; Theo G. M. van Erp, MA; Jukka Huttunen, MD; Sargo Aalto, MSc; Kjell Någren, PhD; Matti Huttunen, MD, PhD; Jouko Lönnqvist, MD, PhD; Jaakko Kaprio, MD, PhD; Jarmo Hietala, MD, PhD; Tyrone D. Cannon, PhD
Topics: positron-emission tomography, raclopride, dopamine d2 receptor, schizophrenia, twins, genetic markers
Arch Gen Psychiatry. 2005;62(4):371-378. doi:10.1001/archpsyc.62.4.371.
Regionally Specific Disturbance of Dorsolateral Prefrontal–Hippocampal Functional Connectivity in Schizophrenia FREE
Andreas S. Meyer-Lindenberg, MD, PhD; Rosanna K. Olsen; Philip D. Kohn; Timothy Brown; Michael F. Egan, MD; Daniel R. Weinberger, MD; Karen Faith Berman, MD
Topics: heart failure, systolic, congestive heart failure, hippocampus (brain), memory, short-term, schizophrenia
Arch Gen Psychiatry. 2005;62(4):379-386. doi:10.1001/archpsyc.62.4.379.
Alterations in Regional Cerebral Glucose Metabolism Across Waking and Non–Rapid Eye Movement Sleep in Depression FREE
Eric A. Nofzinger, MD; Daniel J. Buysse, MD; Anne Germain, PhD; Julie C. Price, PhD; Carolyn C. Meltzer, MD; Jean M. Miewald; David J. Kupfer, MD
Topics: positron-emission tomography, glucose metabolism, metabolism, electroencephalography, depressive disorders, rem sleep, brain, sleep, sleep, slow-wave, depressed mood
Arch Gen Psychiatry. 2005;62(4):387-396. doi:10.1001/archpsyc.62.4.387.
Neuroanatomic Correlates of Psychopathologic Components of Major Depressive Disorder FREE
Matthew S. Milak, MD; Ramin V. Parsey, MD, PhD; John Keilp, PhD; Maria A. Oquendo, MD; Kevin M. Malone, MD; J. John Mann, MD
Topics: anxiety, positron-emission tomography, fibrinogen, depressive disorders, dyssomnia, psychotic disorders, sleep disorders, brain, major depressive disorder
Arch Gen Psychiatry. 2005;62(4):397-408. doi:10.1001/archpsyc.62.4.397.
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression FREE
Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; Jay D. Amsterdam, MD; Richard C. Shelton, MD; Paula R. Young, PhD; Ronald M. Salomon, MD; John P. O’Reardon, MD; Margaret L. Lovett, MEd; Madeline M. Gladis, PhD; Laurel L. Brown, PhD; Robert Gallop, PhD
Topics: pharmacotherapy, cognitive-behavioral therapy, depressive disorders
Arch Gen Psychiatry. 2005;62(4):409-416. doi:10.1001/archpsyc.62.4.409.
Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression FREE
Steven D. Hollon, PhD; Robert J. DeRubeis, PhD; Richard C. Shelton, MD; Jay D. Amsterdam, MD; Ronald M. Salomon, MD; John P. O’Reardon, MD; Margaret L. Lovett, MEd; Paula R. Young, PhD; Kirsten L. Haman, PhD; Brent B. Freeman, BA; Robert Gallop, PhD
Topics: cleft palate, cognitive-behavioral therapy, depressive disorders, relapse prevention, clinically amyopathic dermatomyositis
Arch Gen Psychiatry. 2005;62(4):417-422. doi:10.1001/archpsyc.62.4.417.
Suicide Risk in Relation to Psychiatric Hospitalization:  Evidence Based on Longitudinal Registers FREE
Ping Qin, MD, PhD; Merete Nordentoft, MD, PhD
Topics: suicide, hospitalization, psychiatric, suicide risk assessment
Arch Gen Psychiatry. 2005;62(4):427-432. doi:10.1001/archpsyc.62.4.427.
Impact of 3-Tier Formularies on Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Children FREE
Haiden A. Huskamp, PhD; Patricia A. Deverka, MD, MS; Arnold M. Epstein, MD, MA; Robert S. Epstein, MD, MS; Kimberly A. McGuigan, PhD; Anna C. Muriel, MD; Richard G. Frank, PhD
Topics: pharmacotherapy, attention-deficit/hyperactivity disorder, formulary, spending
Arch Gen Psychiatry. 2005;62(4):435-441. doi:10.1001/archpsyc.62.4.435.
Methamphetamine Users in Sustained Abstinence:  A Proton Magnetic Resonance Spectroscopy Study FREE
Thomas E. Nordahl, MD, PhD; Ruth Salo, PhD; Yutaka Natsuaki, MSc; Gantt P. Galloway, PharmD; Christy Waters, MD; Charles D. Moore, MD; Shawn Kile, MD; Michael H. Buonocore, MD, PhD
Topics: magnetic resonance spectroscopy, methamphetamine, protons, metabolites
Arch Gen Psychiatry. 2005;62(4):444-452. doi:10.1001/archpsyc.62.4.444.
Contact Information FREE
Topics:
Arch Gen Psychiatry. 2005;62(4):456. doi:10.1001/archpsyc.62.4.456.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems